Specify a stock or a cryptocurrency in the search bar to get a summary
Zhejiang Ausun Pharmaceutical Co Ltd
603229Zhejiang Ausun Pharmaceutical Co., Ltd. engages in the research and development, process development, manufacture, and sale of APIs and pharmaceutical intermediates. It offers fluorine products, prostaglandins, antimicrobials, and oncology products. The company also provides products for liver disease, respiratory system, and cardiac and cerebral vessels, as well as CNS indications. In addition, it offers development and manufacturing services to the pharmaceutical, cosmetics, and nutritional industries. The company was founded in 2010 and is based in Linhai, China. Address: No. 5 Donghai Fourth Lane, Linhai, China, 317016
Analytics
WallStreet Target Price
147.47 CNYP/E ratio
27.125Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures 603229
Dividend Analytics 603229
Dividend growth over 5 years
427 %Continuous growth
4 yearsPayout Ratio 5 years average
12 %Dividend History 603229
Stock Valuation 603229
Financials 603229
Results | 2019 | Dynamics |